The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...

I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...

Those eligible for the Novavax Covid-19 vaccine can receive the jab at selected general practitioner (GP) clinics from Jan 2 ...

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...

The EU document dated 11 November was circulated internally after the EU announced its supply deal with Pfizer and its German partner BioNTech on 11 November ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Fact check - Patients who have been vaccinated against Covid-19 do not need to undergo routine D-dimer testing.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

The Vaccine Adverse Event Reporting System (VAERS) was established to protect public health. Now it's being used against it.

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...